Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose left atrium (one of the heart's chambers) measures less than 55 mm in size
- People whose irregular heart rhythm (atrial fibrillation) has come back even while taking heart rhythm medications, or who cannot tolerate those medications
- People for whom a doctor has determined that blood-thinning (anticoagulant) therapy is appropriate to help prevent blood clots
Who may not be able to join:
- People whose atrial fibrillation is linked to serious heart structural problems or heart defects that affect how the heart pumps blood
- People who have difficulty undergoing a CT scan that uses contrast dye (a special liquid used to make images clearer)
- People who currently have active internal bleeding
- People for whom blood-thinning therapy is not considered appropriate
- People with serious additional health conditions (confirm with trial site for specific details)
- People who are not expected to survive beyond one year
- People with a current addiction to drugs or alcohol
- People who are unable to read and understand the consent form (for example, due to literacy or language barriers)
- People who the trial investigators determine are not suitable for participation for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hui-Nam Pak, Severance Hospital, Yonsei University Health System
Phone: 82-2-2228-8459
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of Atrial Fibrillation Catheter Ablation(AFCA); safety of Atrial Fibrillation Catheter Ablation(AFCA)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.